O-GlcNAcylation of AMPA receptor GluA2 is associated with a novel form of long-term depression at hippocampal synapses.
Erica W Taylor, Kai Wang, Amy R Nelson, Teruko M Bredemann, Kyle B Fraser, Sarah M Clinton, Rosemary Puckett, Richard B Marchase, John C Chatham, Lori L McMahon
文献索引:J. Neurosci. 34(1) , 10-21, (2014)
全文:HTML全文
摘要
Serine phosphorylation of AMPA receptor (AMPAR) subunits GluA1 and GluA2 modulates AMPAR trafficking during long-term changes in strength of hippocampal excitatory transmission required for normal learning and memory. The post-translational addition and removal of O-linked β-N-acetylglucosamine (O-GlcNAc) also occurs on serine residues. This, together with the high expression of the enzymes O-GlcNAc transferase (OGT) and β-N-acetylglucosamindase (O-GlcNAcase), suggests a potential role for O-GlcNAcylation in modifying synaptic efficacy and cognition. Furthermore, because key synaptic proteins are O-GlcNAcylated, this modification may be as important to brain function as phosphorylation, yet its physiological significance remains unknown. We report that acutely increasing O-GlcNAcylation in Sprague Dawley rat hippocampal slices induces an NMDA receptor and protein kinase C-independent long-term depression (LTD) at hippocampal CA3-CA1 synapses (O-GcNAc LTD). This LTD requires AMPAR GluA2 subunits, which we demonstrate are O-GlcNAcylated. Increasing O-GlcNAcylation interferes with long-term potentiation, and in hippocampal behavioral assays, it prevents novel object recognition and placement without affecting contextual fear conditioning. Our findings provide evidence that O-GlcNAcylation dynamically modulates hippocampal synaptic function and learning and memory, and suggest that altered O-GlcNAc levels could underlie cognitive dysfunction in neurological diseases.
相关化合物
相关文献:
2014-04-01
[J. Surg. Res. 187(2) , 542-52, (2014)]
2013-01-09
[J. Ethnopharmacol. 145(1) , 311-9, (2013)]
2013-10-01
[Open Biol. 3(10) , 130021, (2013)]
2013-05-01
[Clin. Exp. Immunol. 172(2) , 217-27, (2013)]
2013-05-01
[Diabetes 62(5) , 1537-46, (2013)]